Pivotal Brand and Domain Asset for Sale
for Diabetic Care: DiabeticCare.com
Diabetes Has Staggering and Deadly Statistics
Diabetics have increased to 536.6 million people globally, with a projection to rise 783.2 million people by 2045. Diabetes caused 6.7 million deaths last year. Almost 1 in 2 (240 million) adults living with diabetes are undiagnosed. Global diabetic-related health expenditures were estimated to be $966 billion USD in 2021 and projected to reach $1.054 trillion USD by 2045. There are also an estimated 541 million adults who do not have diabetes yet, but have Impaired Glucose Tolerance (IGT), which places them at high risk of type 2 diabetes in the future.The driving factors of diabetes are Obesity, with 1.9 billion adults overweight. Compound lifestyle risk factors such as smoking, overweight, obesity, sedentary lifestyle and high cholesterol are expected to boost the prevalence of diabetes. This includes children all the way through senior demographics.
“The 10th edition of the IDF Diabetes Atlas suggests that in 2021 more than 1 in 10 adults now have diabetes globally and that the number of people with diabetes will continue to expand rapidly in the future. As our projections only consider demographic changes in populations relating to ageing and urbanisation, and not changes in risk factor prevalence or in survival, it is likely that our projected increases over time are conservative.” [Emphasis added] Source: Diabetes Research and Clinical Practice
The Blood Glucose Monitoring (BGM) device market and Insulin Delivery Device market are the part of diabetic care market highlighted the most in market size industry reports. As shown here, in this report by Grand View Research, the size of the diabetic device market alone is significant:
How Can DiabeticCare.com Help Improve Diabetic Lives and Diabetic Statistics?
What does all this mean? These numbers are daunting. Diabetes impacts so many lives, and the magnitude of the problem can be overwhelming from the high overview level of macro impact, but also it is overwhelming at the deeply personal level of each individual patient, and the families that love them.
The company that commits to serving these patients, to help them attain a better level of health, and manage all the aspects of their bodies that diabetes impacts ,will be in a unique position to transform individuals and society as a whole, into better health and a better quality of life. Further, the company that helps a diabetic win, also impacts the entire family of those diabetics, and the world they walk in socially, vocationally and economically. Not only could a comprehensive diabetic care model improve eye sight, foot pain, toe viability, neuropathy, infection levels, kidney strength, well being and viability, it could reduce complications and death in other sectors of health. In short, the company that sees a vision of improving the lives of so many will be recognized by those patients, families and advocates as world changers.
This powerful asset DiabeticCare.com needs to be in the right hands of a company that accepts the challenge to be those world changers. DiabeticCare.com is a powerful, all-encompassing, patient-centric brand that is focused on the whole patient. By educating and helping to solve all aspects of managing diabetic care for that patient, this platform could be the single most important tool for prevention and treatment of diabetic patients in a comprehensive way that could improve lives globally.Note that diabetics don’t just need devices for sugar monitoring and insulin delivery. They need skincare, eye care, lymphedema care, foot care, dietary care, exercise guidance, mindset coaching, family integration, and more. They need education and encouragement from professionals and from people in the same condition, who have overcome on many levels. In addition to sustaining and breakthrough pharmaceuticals, they need proven supplements and therapies that can give the patients a winning combination of weapons in their battle.
Note that diabetics don’t just need devices for sugar monitoring and insulin delivery. They need skincare, eye care, lymphedema care, foot care, dietary care, exercise guidance, mindset coaching, family integration, and more. They need education and encouragement from professionals and from people in the same condition, who have overcome on many levels.
DiabeticCare.com could and should be the go-to resource for half a billion diabetic patients around the world. Only ONE COMPANY will own this incredible resource, and have the power to impact so many people with a medical and lifestyle brand.
Are you that company?
If you are that company, reach out to us today
Note: We have helped many firms acquire important keyword domains over the last 3 decades,
and are conscientious to make sure that every transaction is a smooth experience.
This includes startups, small businesses, growing mid-size businesses and even large corporations.
You might recognize brands like Purina, Shire, Allergan, McAfee and Pinduoduo..
We treat every size customer with the same commitment to a great relationship.
Diabetic Care Market Reports
Diabetic Care [Device] Market Valuation by Emergen:
- $20.3 billion USD in 2020
- $38.74 billion forecast by 2028
- Dominant devices are for glucose monitoring (self testing and continuous monitoring),
and insulin delivery devices (pumps, pens, syringes and jet injectors)
- North America accounts for 39.1% of global revenue
- The market is consolidating with a few players accounting for majority of revenue
- Glucose monitoring devices expect CAGR of 8.3% over2022- 2027 forecast period
- Source: Emergen Research: Diabetes Care Market By Devices
Diabetes Care [Devices] Market Valuation by Mordor Intelligence:
- $52 billion USD in 2021
- $73 billion USD by 2027
- Currently, about 10% of all diabetes cases are Type-1, and the remaining are Type-2
- The Diabetes Care Devices Market is segmented by Management Devices
(Insulin Pumps, Insulin Syringes, Insulin Cartridges, Disposable Pens, and Jet Injectors),
Monitoring Devices (Self-monitoring Blood Glucose and Continuous Glucose Monitoring),
and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and Latin America).
- CAGR of 5% over 2022- 2027 forecast period
- Source: Mordor Intelligence: Diabetes Care Devices Market Size
Diabetes Care [Devices] Market Valuation by Allied Market Research:
- The global Diabetes Care Devices Market Size was valued at $20.0 billion in 2020
- Projected to reach $38.3 billion by 2030
- Growing at CAGR of 6.6% from 2021 to 2030
- The key factor that drives the Diabetes Care Devices Market Growth includes
an increase in the incidence of diabetes and a change in urbanization & sedentary lifestyle.
- On the basis of product, the market is bifurcated into blood glucose monitoring
devices and insulin delivery devices.
- Source Allied Market Research: Diabetes Care Devices Market Size
Diabetes Care [Devices] Market Valuation by Straits Research :
- Straits Research Reports (June 29, 2022) Diabetes Has Reached Epidemic Proportions:
- Diabetes Care Devices Market to reach $87.15B by 2030
- North America market alone will reach $40.67B by 2030
- Type 1 diabetes is insulin-dependent, and Type 2 diabetes is also insulin-dependent.
- Diabetes is associated with several health problems. People with diabetes are 300%
more likely to be hospitalized, and as a result, they incur higher healthcare costs than
those without diabetes.
- New York, United States, June 29, 2022 (GLOBE NEWSWIRE) — Diabetes is a life-threatening,
chronic disorder for which there is no treatment.
- Source Straits Research: Diabetes Care Devices Market Size
Diabetes Care [Devices] Market Valuation by Bcc Research:
- The global market for diabetes monitoring devices should grow from $19.7
- A compound annual growth rate (CAGR) of 6.5% for the period of 2020-2025.
- The scope of the report includes an overview of the global market for diabetes
monitoring devices and analyses of global market trends, using 2019 as the base year
and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections.
- Regional analysis includes North America (U.S., Canada, Mexico), Europe
(U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific
(China, India, Japan and Rest of Asia-Pacific), South America, and the Middle East and Africa.
- Source Bcc Research: Diabetes Care Devices Market Size
Key Companies in the Diabetic Care Space:
- Eli Lilly And Company
- Medtronic PLC
- Ypsomed Holdings
- Hoffman La Roche
- Novo Nordisk
- Insulet Corporation
- Abbott Laboratories
- Becton Dickinson
- Life Scan Holdings LLC
- One Drop
- Byram Healthcare
- Abbott laboratories
- Acon laboratories
- Johnson & Johnson
- Terumo Corporation
- Ascensia Diabetes Care
- Bionime Corporation
- Rossmax International Ltd.
Types of Diabetic
Type 1 Diabetic
When you have type 1 diabetes, your body still breaks down the carbohydrate from food and drink and turns it into glucose. But when the glucose enters your bloodstream, there’s no insulin to allow it into your body’s cells. More and more glucose then builds up in your bloodstream, leading to high blood sugar levels.
Type 2 Diabetic
Having type 2 diabetes without treatment means that high sugar levels in your blood can seriously damage parts of your body, including your eyes, heart and feet. These are called the complications of diabetes. But with the right treatment and care, you can live well with type 2 diabetes and reduce your risk of developing them.
Gestational diabetes is diabetes that can develop during pregnancy. It affects women who haven’t been affected by diabetes before. It means you have high blood sugar and need to take extra care of yourself and your bump. This will include eating well and keeping active.
Maturity onset diabetic of the young (MODY)
]MODY is a rare form of diabetes which is different from both type 1 and type 2 diabetes, and runs strongly in families. MODY is caused by a mutation (or change) in a single gene. If a parent has this gene mutation, any child they have, has a 50 per cent chance of inheriting it from them. If a child does inherit the mutation they will generally go on to develop MODY before they’re 25, whatever their weight, lifestyle, ethnic group etc.
Neonatal diabetes is a form of diabetes that is diagnosed under the age of six months. It’s a different type of diabetes than the more common type 1 diabetes as it’s not an autoimmune condition (where the body has destroyed its insulin producing cells).
Wolfram Syndrome is a rare genetic disorder which is also known as DIDMOAD syndrome after its four most common features (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness).
Alström Syndrome is a rare genetically inherited syndrome which has a number of common features.
Latent autoimmune diabetic in adults (LADA)
LADA is a type of diabetes which seems to straddle type 1 and type 2 diabetes. Bits of it are more like type 1, and other bits are more like type 2. That’s why some people call it type 1.5 diabetes or type 1 ½ diabetes.
Type 3c diabetic
Type 3c diabetes is a type of diabetes that develops when another disease causes damage to the pancreas. The conditions related to type 3c are pancreatic cancer, pancreatitis, cystic fibrosis or haemochromatosis. You can also develop type 3c if you have part or all of your pancreas removed because of other damage.
Some people who take steroids can go on to develop diabetes. This is known as steroid-induced diabetes, and is more common in people who are at higher risk of type 2 diabetes.